Product fact sheet

BON CHARGE Mini Red Light Device: Technical Specifications

Name: BON CHARGE Mini Red Light Device
Brand: BON CHARGE

BON CHARGE Mini is a rechargeable 12-LED device with manufacturer-published 660 nm and 850 nm output, compact dimensions and a general-use beauty positioning.

Red-light therapy guideReturn to the therapy guide and compare device specifications in context. Compare in context → Red-light panel comparisonOpen the comparison surface for this product family; missing comparable data is shown rather than guessed. Compare products →

Manufacturer documentedFacts checked 2026-08-11

A rechargeable two-wavelength handheld device with primary manufacturer specifications and a current manual index, but no normalized independent radiometric report in the Homeapotherapy record.

Fit signals

portable targeted-use specification comparisons, buyers comparing battery-powered red-light hardware

Potential constraints

buyers requiring independent irradiance verification, large-area panel comparisons

Key tradeoff: The compact battery format is well documented by the manufacturer, while its published irradiance cannot be normalized against calibrated third-party panel measurements without method details.

This is a factual fit-and-tradeoff summary, not a product recommendation. Formula, device and brand claims remain manufacturer claims unless the cited source is explicitly regulatory or independent testing.

The BON CHARGE Mini is a rechargeable targeted-use red-light device with manufacturer-published 660 nm red and 850 nm near-infrared output and a 12-LED architecture.

What the manufacturer record establishes

The current product specification lists a compact 15 × 9.5 × 4 cm body, 0.73 kg weight, 36 W published power, and 4.2 V rechargeable electrical specification.

BON CHARGE also publishes an irradiance figure for the device. That value should not be treated as directly equivalent to LightLab measurements because the current source record does not establish an equivalent spectral band, calibrated instrument, geometry and spatial-averaging method.

Intended-use language

The manufacturer’s current page describes this model as a general-use beauty product. That wording is preserved as manufacturer scope; it is not converted into a medical-device or clinical-efficacy claim.

Independent-measurement gap

No independent radiometric report using a compatible common protocol is attached to the current record. Optical output, battery runtime, thermal behavior and long-term performance have not been independently measured here.

The compact rechargeable format is the product’s clearest practical distinction from mains-powered panels. That convenience does not resolve the measurement gap, so published irradiance should remain source-labeled rather than normalized against unlike lab methods.

See Red Light Device Specifications Explained for why unlike irradiance methods are kept separate.

Technical specifications

Published specs and what they mean

Physical

Dimensions: 15 × 9.5 × 4 cm (5.9 × 3.7 × 1.6 in)
Weight: 0.73 kg (1.6 lb)

Optical

Published wavelengths: 660 / 850 nm
LED count: 12 × 3 W LEDs

Electrical

Published voltage: 4.2 V
Published power: 36 W

Regulatory

Intended-use language: Manufacturer describes it as a general-use beauty product

What the current record does not establish

No independent common-protocol irradiance measurement is normalized.
The manufacturer publishes an irradiance claim but the current normalized record does not establish equivalent spectral band, instrument or spatial averaging conditions.
Homeapotherapy has not hands-on tested battery life, thermal behavior or optical output.

A missing field is not evidence that the device lacks the feature or performs poorly. It means we do not currently have a sufficiently comparable, sourced value in the normalized record.

Source labels preserve provenance. Manufacturer specifications, ingredient lists and performance claims are not treated as independent clinical evidence; regulatory records and independent measurements are identified separately when available.

Dose and irradiance context

What the output number means over time

Fluence is a calculation, not a treatment recommendation. For continuous output, fluence in J/cm² equals irradiance in mW/cm² × seconds ÷ 1000. The calculation only remains meaningful at the measurement conditions used for the irradiance value.

No comparable independent average irradiance is normalized

This device may have a manufacturer-published irradiance claim, but Homeapotherapy does not calculate time-to-fluence from that number unless the current record contains a sufficiently defined independent area-average measurement. This avoids presenting unlike measurement methods as interchangeable.

What this calculation still cannot tell you

whether this is an effective dose for any condition;
how irradiance changes at a different distance or across curved anatomy;
how much energy reaches tissue below the surface;
whether a study used the same wavelength distribution, spot size, pulse mode or treatment schedule;
whether peak irradiance would produce the same area exposure as the average value shown here.

Read Red Light Irradiance, Fluence and Dose Explained before trying to compare this output with a clinical paper or another panel.

Clinical evidence context

Where these wavelengths overlap with human research

Published device wavelengths: 660 / 850 nm.

This is a hardware-to-literature cross-reference, not a claim that this product treats any condition. A matching nominal wavelength does not reproduce a study's irradiance, dose, distance, treatment area, emitter geometry, schedule or patient population.

Research areas worth checking

Pattern hair loss — human studies commonly use visible-red wavelengths, especially around the mid-600 nm range.
Acne and inflammatory skin — red-light protocols exist, but acne studies may also use blue light and should not be generalized from panel specs.
Skin rejuvenation and photoaging — visible-red and red/NIR LED protocols have been studied with varied devices and endpoints.
Knee osteoarthritis — near-infrared wavelengths appear in the clinical literature, but wavelength alone does not establish an equivalent treatment protocol.
Muscle recovery and musculoskeletal pain — research spans red and near-infrared bands with substantial protocol variation.
Transcranial PBM and cognition — some research uses near-infrared wavelengths, but a body panel is not automatically equivalent to a head-targeted transcranial device.
See the full wavelength-by-condition evidence chart for evidence strength, treatment geometry and major caveats.

Do not infer from wavelength overlap

that this device is clinically proven for the linked condition;
that more wavelengths are better;
that the highest published irradiance is the best dose;
that an open wound should be treated with a consumer device without appropriate wound assessment.

For wounds specifically, start with the wound-care safety decision guide before interpreting any device specification.

Safety first

What should make you slow down?

Use the product as directed, avoid treating concentrated wellness products as automatically harmless, and ask a qualified clinician when your situation or medication use makes the decision less routine.

Where to buy

Current tracked merchants

Commerce note: merchant economics never enter our editorial score. Affiliate links are identified as (paid link) and use sponsored-link markup.

No merchant destination is currently tracked for this product.

Source trail

Primary documents and supporting evidence

Mini Red Light DeviceBON CHARGE · Manufacturer · retrieved 2026-08-11
BON CHARGE Product User ManualsBON CHARGE · Manufacturer manual · Manual index · retrieved 2026-08-11

Comparable products